Medicared For All Logo

Crystal Lagalle in N Kansas City, Missouri

Home Missouri N Kansas City

Crystal Lagalle has Internal Medicine as her primary medical specialty. Their primary office is: 2700 Clay Edwards Dr in N Kansas City, Missouri. There are 2 additional office locations for Crystal Lagalle that can be viewed towards the end of their profile.

They're a part of the: Meritas Health Corporation medical group which has around 349 members. You can call their office at 816-421-4240 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2010 (around 14 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Crystal D Lagalle Office Phone and Directions

Crystal Lagalle
Meritas Health Corporation
2700 Clay Edwards Dr
N Kansas City, Missouri 64116
816-421-4240


Patient Ratings
Please rate your experience with Crystal Lagalle below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 816-421-4240


Enter a starting address:


Healthcare Info for Crystal Lagalle

Medical School: Sorry, her university is not listed
Graduation Year: 2010
The Primary Medical Specialty for Crystal Lagalle is listed as: Internal Medicine
Approximate Years of Experience: 14
PAC (PECOS ID)#: 2466673009
NPI #: 1891010666
NPI Created On: 04/05/2010
NPI Last Updated Listed as: 06/30/2015
Primary Taxonomy Code: 207R00000X
License Number:
2014011936
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medica Insurance Company
  • Celtic Insurance Company
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Hemoglobin a1c level
  2. Vaccine for influenza for injection into muscle
  3. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
  4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  5. Established patient office or other outpatient visit, typically 15 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Initial hospital inpatient care, typically 70 minutes per day
  9. Subsequent hospital inpatient care, typically 25 minutes per day
  10. Hospital discharge day management, more than 30 minutes
  11. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
  12. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
  13. Administration of influenza virus vaccine
  14. Administration of pneumococcal vaccine
  15. Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
  16. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
  17. Annual depression screening, 15 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788788895

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788788897

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795199053

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795199059

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: CREON

Open Associated Drug #1: 0032-3016-13


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795199063

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GASTROENTEROLOGY

Name of Drug #1: LINZESS

Open Associated Drug #1: 0456-1201-30


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795199069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: QULIPTA

Open Associated Drug #1: 0074-7094-30


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795199075

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795199081

Being Disputed:: No

Product Related: No


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795199087

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819024415

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: TRULICITY

Open Associated Drug #1: 0002-1433-80

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: JARDIANCE

Associated Drug #2: 0597-0152-37


Additional Office Locations

1. Meritas Health Corporation
9411 N Oak Trafficway
Kansas City, MO 64155
Suite 260
Group Members: 349

Phone: 816-421-4240

Enter a starting address:


2. Meritas Health Corporation
9411 N Oak Trfy
Kansas City, MO 64155
Suite 260
Group Members: 349

Phone: 816-421-4240

Enter a starting address:


Internal Medicine Professionals in N Kansas City

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

2700 Clay Edwards Dr
N-kansas-city, MO
Meritas Health Corporation

Providers in Meritas Health Corporation

1.Avery Abernathy

6450 N Chatham Ave
Kansas City Mo 64151-2403
Meritas Health Corporation
Family Practice

2.Antonette Acosta-dickson Md

2800 Clay Edwards Dr
North Kansas City Mo 64116-3220
Meritas Health Corporation
Family Practice

3.Antonette Acosta-dickson Md

6450 N Chatham Ave
Kansas City Mo 64151-2403
Meritas Health Corporation
Family Practice

4.Samin Akhtar Md

2700 Clay Edwards Dr
N Kansas City Mo 64116-3270
Meritas Health Corporation
Internal Medicine

5.Drew Allen

2790 Clay Edwards Dr
North Kansas City Mo 64116-3274
Meritas Health Corporation
Cardiovascular Disease (cardiology)

6.Drew Allen

9411 N Oak Trafficway
Kansas City Mo 64155-2281
Meritas Health Corporation
Cardiovascular Disease (cardiology)

View all 349 members of Meritas Health Corporation medical group